Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-08-03 Sale |
2020-08-05 6:47 pm |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
80,000 | $27.23 | $2,178,066 | 7,698,783 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-11-24 Ownership |
2021-02-12 4:15 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
740,650 | $0 | 5,888,121 (Indirect) |
View |
Ownership |
2021-02-12 4:15 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
0 | $0 | 5,888,121 (Direct) |
View |
| 2020-11-16 Tax Withholding |
2020-11-18 7:51 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
1,774 | $44.33 | 7,777,304 (Direct) |
View |
| 2020-11-16 Exercise |
2020-11-18 7:51 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
5,129 | $0 | 7,777,304 (Direct) |
View |
| 2020-08-16 Exercise |
2020-08-18 7:02 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
5,129 | $0 | 7,779,078 (Direct) |
View |
| 2020-08-16 Tax Withholding |
2020-08-18 7:02 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
1,774 | $28.53 | 7,779,078 (Direct) |
View |